Protagonist Therapeutics, Inc (PTGX) — Analysis Summary
Protagonist Therapeutics, Inc (PTGX) has a market cap of $6.33B with year-over-year revenue growth of +624.1%. Net margin stands at 63.3%. The stock trades at a P/E ratio of 23.0.
Key Takeaways
- Revenue changed +624.1% year-over-year
- Net margin of 63.3%
- P/E ratio of 23.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, PTGX posted revenue growth of +624.1% and trades at a P/E of 23.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.